Astera Labs (NASDAQ:ALAB) Stock Price Down 3.1% – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price dropped 3.1% on Monday . The company traded as low as $267.74 and last traded at $282.52. Approximately 4,100,365 shares changed hands during trading, a decline of 26% from the average daily volume of 5,538,956 shares. The stock had previously closed at $291.58.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on ALAB shares. TD Cowen boosted their price target on shares of Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. raised their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Susquehanna lifted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Barclays boosted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $282.00.

Astera Labs Trading Down 3.1%

The stock has a fifty day simple moving average of $358.95 and a two-hundred day simple moving average of $226.07. The firm has a market cap of $48.43 billion, a PE ratio of 190.89, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the firm posted $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the firm’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the completion of the transaction, the director directly owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. The trade was a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock worth $444,928,806 in the last ninety days. Insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently added to or reduced their stakes in ALAB. Reflection Asset Management purchased a new position in Astera Labs during the fourth quarter worth about $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs in the 4th quarter valued at about $33,000. Whipplewood Advisors LLC raised its holdings in shares of Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares in the last quarter. Finally, Assetmark Inc. boosted its position in shares of Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after acquiring an additional 101 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.